146 related articles for article (PubMed ID: 38006954)
1. Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination.
Zhan XY; Chen H; Kong H; Meng T; Ye J; Liu Y; Ng MHL; Li L; Zhang Y; Huang J; Peng Q; Chen C; He Y; Yang M
Immunol Lett; 2023 Dec; 264():56-63. PubMed ID: 38006954
[TBL] [Abstract][Full Text] [Related]
2. Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia.
Kaicker S; Martinko K; Bussel JB
Pediatr Blood Cancer; 2023 Jan; 70(1):e30051. PubMed ID: 36317671
[TBL] [Abstract][Full Text] [Related]
3. Exacerbation of immune thrombocytopenia following COVID-19 vaccination.
Kuter DJ
Br J Haematol; 2021 Nov; 195(3):365-370. PubMed ID: 34075578
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccination in patients with immune thrombocytopenia.
Visser C; Swinkels M; van Werkhoven ED; Croles FN; Noordzij-Nooteboom HS; Eefting M; Last-Koopmans SM; Idink C; Westerweel PE; Santbergen B; Jobse PA; Baboe F; ; Te Boekhorst PAW; Leebeek FWG; Levin MD; Kruip MJHA; Jansen AJG
Blood Adv; 2022 Mar; 6(6):1637-1644. PubMed ID: 34941989
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination.
Feng Y; Quan Y; Cassady K; Zou Z; Gao Y; Zhang X
Hum Vaccin Immunother; 2022 Nov; 18(6):2119043. PubMed ID: 36069667
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine.
Aharoni M; Leader A; Shochat T; Raanani P; Spectre G
Platelets; 2022 Jul; 33(5):781-786. PubMed ID: 35536172
[TBL] [Abstract][Full Text] [Related]
7. Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.
Bidari A; Asgarian S; Pour Mohammad A; Naderi D; Anaraki SR; Gholizadeh Mesgarha M; Naderkhani M
Eur J Haematol; 2023 Apr; 110(4):335-353. PubMed ID: 36562217
[TBL] [Abstract][Full Text] [Related]
8. Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
Ruzicka M; Wurm S; Lindner L; Dreyling M; von Bergwelt-Baildon M; Boeck S; Giessen-Jung C; Milani V; Stemmler JH; Subklewe M; Weigert O; Spiekermann K
Infection; 2023 Feb; 51(1):231-238. PubMed ID: 36195695
[TBL] [Abstract][Full Text] [Related]
9. New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience.
Chou SC; Chang YC; Liao CK; Chen TC; Sun KJ; Huang WH; Wu YF
Platelets; 2022 May; 33(4):531-535. PubMed ID: 35196955
[TBL] [Abstract][Full Text] [Related]
10. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.
Tarantino MD; Fogarty PF; Shah P; Brainsky A
Platelets; 2015; 26(1):93-6. PubMed ID: 24433306
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID-19 in a tertiary center - A monocentric analysis.
Schaefers C; Paulsen FO; Frenzel C; Weisel K; Bokemeyer C; Seidel C
Br J Haematol; 2023 Apr; 201(2):222-226. PubMed ID: 36793157
[TBL] [Abstract][Full Text] [Related]
12. A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination.
King ER; Towner E
Am J Case Rep; 2021 Jul; 22():e931478. PubMed ID: 34285180
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB
Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251
[TBL] [Abstract][Full Text] [Related]
14. Comparative study between two bleeding grading systems of immune thrombocytopenia purpura.
Chen Q; Zhang Y; Li Y; Zhang L; Shi W; Tao H; Chen K; He Z; Wang C; Yu L
Hematology; 2021 Dec; 26(1):769-774. PubMed ID: 34565307
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.
Wong RSM; Saleh MN; Khelif A; Salama A; Portella MSO; Burgess P; Bussel JB
Blood; 2017 Dec; 130(23):2527-2536. PubMed ID: 29042367
[TBL] [Abstract][Full Text] [Related]
16. Real-world, single-center experience of SARS-CoV-2 vaccination in immune thrombocytopenia.
Woolley P; Tailor A; Shah R; Westwood JP; Scully M
J Thromb Haemost; 2022 Jun; 20(6):1476-1484. PubMed ID: 35313390
[TBL] [Abstract][Full Text] [Related]
17. Severe immune thrombocytopenia following diphtheria, tetanus, pertussis and polio vaccination in a 36-year-old Caucasian woman: a case report.
Küster O; Schmohl J; Greiner J; Storz MA
Eur J Med Res; 2022 May; 27(1):63. PubMed ID: 35505368
[TBL] [Abstract][Full Text] [Related]
18. Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine.
Saudagar V; Patil S; Goh S; Pothiawala S
Ir J Med Sci; 2022 Apr; 191(2):919-920. PubMed ID: 33788135
[TBL] [Abstract][Full Text] [Related]
19. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
Bussel JB; Provan D; Shamsi T; Cheng G; Psaila B; Kovaleva L; Salama A; Jenkins JM; Roychowdhury D; Mayer B; Stone N; Arning M
Lancet; 2009 Feb; 373(9664):641-8. PubMed ID: 19231632
[TBL] [Abstract][Full Text] [Related]
20. Comparative Study of the Clinical Application of 2 Bleeding Grading Systems for Pregnant Women With Immune Thrombocytopenia.
Huang J; Zeng B; Li X; Huang M; Zhan R
Clin Appl Thromb Hemost; 2020; 26():1076029620910790. PubMed ID: 32392082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
